Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure

被引:19
作者
Chirinos, Julio A. [1 ,2 ,3 ]
Sardana, Mayank [4 ]
Oldland, Garrett [1 ,2 ]
Ansari, Bilal [3 ]
Lee, Jonathan [2 ]
Hussain, Anila [3 ,5 ]
Mustafa, Anique [3 ]
Akers, Scott R. [1 ]
Wei, Wen [5 ]
Lakatta, Edward G. [5 ]
Fedorova, Olga V. [5 ]
机构
[1] Corporal Michael J Crescenz VAMC, Philadelphia, PA USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[4] Univ Massachusetts, Med Sch, Worcester, MA 01605 USA
[5] NIA, Baltimore, MD 21224 USA
来源
ESC HEART FAILURE | 2018年 / 5卷 / 05期
基金
美国国家卫生研究院;
关键词
Arginine vasopressin; Heart failure with preserved ejection fraction; Left ventricular hypertrophy; Left atrium; Atrial natriuretic peptide; MYOCARDIAL-INFARCTION; COPEPTIN; ACTIVATION; SYSTEM; HYPERTROPHY; DYSFUNCTION; INCREASES; BLOCKADE; RELEASE; TRIAL;
D O I
10.1002/ehf2.12319
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsThe arginine vasopressin (AVP) pathway has been extensively studied in heart failure (HF) with reduced ejection fraction (HFrEF), but less is known about AVP in HF with preserved EF (HFpEF). Furthermore, the association between AVP and atrial natriuretic peptide (ANP, a well-known inhibitor of AVP secretion) in HF is unknown. Methods and resultsWe studied subjects with HFpEF (n=28) and HFrEF (n=25) and without HF (n=71). Left ventricular (LV) mass and left atrial (LA) volumes were measured with cardiac magnetic resonance imaging. Arginine vasopressin and ANP were measured with enzyme-linked immunosorbent assay. Arginine vasopressin levels were significantly greater in HFpEF [0.96pg/mL; 95% confidence interval (CI)=0.83-1.1pg/mL] compared with subjects without HF (0.69pg/mL; 95% CI=0.6-0.77pg/mL; P=0.0002). Heart failure with preserved ejection fraction (but not HFrEF) was a significant predictor of higher AVP after adjustment for potential confounders. Arginine vasopressin levels were independently associated with a greater LA volume and also paradoxically, with lower ANP levels. Key independent correlates of higher AVP were the presence of HFpEF (standardized =0.32; 95% CI=0.09-0.56; P=0.0073) and the ANP/LA volume ratio (standardized =-0.23; 95% CI=-0.42 to -0.04; P=0.0196). Arginine vasopressin levels were independently associated with LV mass (=0.26; 95% CI=0.09-0.43; P=0.003) and with an increased risk of death or HF admissions during follow-up (hazard ratio=1.61; 95% CI=1.13-2.29; P=0.008). ConclusionsArginine vasopressin is increased in HFpEF and is associated with LV hypertrophy and poor outcomes. Higher AVP is associated with the combination of LA enlargement and paradoxically low ANP levels. These findings may indicate that a relative deficiency of ANP (an inhibitor of AVP secretion) in the setting of chronically increased LA pressure may contribute to AVP excess.
引用
收藏
页码:912 / 920
页数:9
相关论文
共 27 条
[1]   Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure [J].
Alehagen, Urban ;
Dahlstroem, Ulf ;
Rehfeld, Jens F. ;
Goetze, Jens P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (20) :2088-2095
[2]  
[Anonymous], 2016, J NEUROENDOCRINOL
[3]   Gender and renal function influence plasma levels of copeptin in healthy individuals [J].
Bhandari, Sanjay S. ;
Loke, Ian ;
Davies, Joan E. ;
Squire, Ian B. ;
Struck, Joachim ;
Ng, Leong L. .
CLINICAL SCIENCE, 2009, 116 (3-4) :257-263
[4]   Neurohormonal activation in congestive heart failure and the role of vasopressin [J].
Chatterjee, K .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (9A) :8B-13B
[5]   Left Ventricular Mass Allometric Scaling, Normative Values, Effect of Obesity, and Prognostic Performance [J].
Chirinos, Julio A. ;
Segers, Patrick ;
De Buyzere, Marc L. ;
Kronmal, Richard A. ;
Raja, Muhammad W. ;
De Bacquer, Dirk ;
Claessens, Tom ;
Gillebert, Thierry C. ;
St John-Sutton, Martin ;
Rietzschel, Ernst R. .
HYPERTENSION, 2010, 56 (01) :91-U137
[6]   Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study [J].
de Simone, Giovanni ;
Gottdiener, John S. ;
Chinali, Marcello ;
Maurer, Mathew S. .
EUROPEAN HEART JOURNAL, 2008, 29 (06) :741-747
[7]   Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy [J].
Diez, Javier .
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (02) :167-176
[8]   Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-κB activation and its relation with myocardial fibrosis [J].
Fan, Yan-Hong ;
Zhao, Lian-You ;
Zheng, Qiang-Sun ;
Dong, Hui ;
Wang, Hai-Chang ;
Yang, Xue-dong .
LIFE SCIENCES, 2007, 81 (04) :327-335
[9]   Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia [J].
Finley, John J. ;
Konstam, Marvin A. ;
Udelson, James E. .
CIRCULATION, 2008, 118 (04) :410-421
[10]   COMPARISON OF NEUROENDOCRINE ACTIVATION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION WITH AND WITHOUT CONGESTIVE-HEART-FAILURE - A SUBSTUDY OF THE STUDIES OF LEFT-VENTRICULAR DYSFUNCTION (SOLVD) [J].
FRANCIS, GS ;
BENEDICT, C ;
JOHNSTONE, DE ;
KIRLIN, PC ;
NICKLAS, J ;
LIANG, CS ;
KUBO, SH ;
RUDINTORETSKY, E ;
YUSUF, S .
CIRCULATION, 1990, 82 (05) :1724-1729